Black Raspberry Nectar for the Prevention of Lung Cancer, BE WELL Study

• Status: Active, not recruiting
• Trial end date: 2022-12-31
• Target enrollment: 0
• Participant gender: All

Summary

This trial studies how well black raspberry nectar works in changing the gut microbiome and in reducing inflammatory processes that may lead to lung cancer. Studying the effects of black raspberry beverage on inflammation may help doctors find strategies to reduce the risk of developing lung cancer.

• Phase: Early Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Ohio State University Comprehensive Cancer Center
• Collaborator: National Cancer Institute (NCI)

Criteria

Inclusion Criteria:

• Have a 30 pack-year smoking history

• Be either a current smoker or a former smoker that quit in the last 15 years. Any individual who is currently smoking and has smoked more than 100 cigarettes in their lifetime will be identified as a current smoker

• Agree to consume a standardized vitamin / mineral supplement and avoid other nutritional, dietary or alternative medications / supplements / probiotics for the duration of the study

• Agree to follow a berry-free / controlled phenolic diet and to document consumption of polyphenolic foods each day of the study using a simple daily form

Exclusion Criteria:

• Person has an allergy to any berries, pectin, or food colorants apples,as well as kiwi fruit, strawberries, soy sauce, pine nuts, almonds, cherries, peaches, blackberries, pears

• Person states that they are not a:

• Current smoker: active cigarette smoker who has smoked more than 30 pack-years in the last 15 years OR

• Former smoker: not a current smoker active cigarette smoker who has smoked more than 30 pack years in the last 15 years

• Person is unwilling to follow a berry-free/controlled polyphenol diet while on study

• Person has history of metabolic disorders (diabetes, hyper/hypo-thyroidism, etc.); digestive illness which may result in nutrient malabsorption (Crohn's disease, Celiac, renal/hepatic insufficiency, short bowel, etc.); disorders that affect connective tissues; or blood clotting disorders

• Person has allergy or food intolerance to ingredients in study products (black raspberries or other berries)

• Person is on a regimen of any of the following medications:

• Immunosuppressants, bisphosphonates, or steroids.

• Anticoagulants (warfarin, apixaban, dabigatran, and rivaroxaban)

• Probiotics

• Person is undergoing treatment for cancer in any form

• Person is currently pregnant or nursing or plans to become pregnant during this study

• Person plans to enter smoking cessation or change their smoking status during the course of the study